Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, and Kelun-Biotech (6990.HK) today ...

Signed malware backed by a stolen EV certificate deployed legitimate RMM tools to gain persistent access inside enterprise ...

Synaptics® Incorporated (Nasdaq: SYNA) today announced the SYN765x, an AI-native wireless solution that redefines Edge intelligence. As an industry-leading single-chip device combining AI-optimized ...

McDonald’s, another brand synonymous with great marketing and advertising, primarily uses AI to improve internal efficiencies. Marketing chief Annabel Fribence told B&T that it is deployed as a ...

BIM-IOL System off all topical IOP-lowering therapy at 12-months100% of BIM-IOL System patients achieved 20/32 or better BCDVA and a mean BCDVA equivalent to 20/20 vision, demonstrating high quality ...

SHENZHEN CITY, GUANGDONG PROVINCE, CHINA, March 9, 2026 /EINPresswire.com/ -- The global slip ring market has entered a ...

The settlement battleground The rapid expansion of tokenised asset issuance and trading venues is reshaping financial market ...

BIM-IOL System off all topical IOP-lowering therapy at 12-months100% of BIM-IOL System patients achieved 20/32 or better BCDVA and a mean BCDVA equivalent to 20/20 vision ...

Collaboration will evaluate INOVIO's INO-5412 (INO-5401 plus INO-9012) in combination with Akeso's cadonilimab as a potential treatment for glioblastoma (GBM), the most common and aggressive ...

INOVIO , and Akeso, Inc. (9926.HK) ("Akeso") today announced that they have entered into a clinical trial collaboration and supply agreement to evaluate INO-5412, INOVIO's DNA immunotherapy candidate, ...